FDA Warning Letter Sends Amphastar Shares Lower in Premarket Trade
Amphastar Pharmaceuticals faces regulatory scrutiny after a subsidiary received an FDA warning over manufacturing violations at a California facility. Amphastar Pharmaceuticals (AMPH) shares fell in premarket trading after the company revealed its subsidiary, International